ICU Medical Inc
General ticker "ICUI" information:
- Sector: Health Care
- Industry: Health Care Equipment & Supplies
- Capitalization: $3.9B
ICU Medical Inc follows the US Stock Market performance with the rate: 65.0%.
Estimated limits based on current volatility of 1.6%: low 151.90$, high 156.97$
Factors to consider:
- US accounted for 63.7% of revenue in the fiscal year ended 2023-12-31
- Current price 19.8% above estimated high
- Earnings for 9 months up through Q3 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2023-12-31 to 2025-12-30
- 2023-12-31 to 2024-12-30 estimated range: [73.18$, 129.10$]
- 2024-12-30 to 2025-12-30 estimated range: [77.91$, 132.16$]
Financial Metrics affecting the ICUI estimates:
- Negative: Operating profit margin, % of 1.01 <= 1.03
- Positive: Non-GAAP EPS, $ of 6.76 > 2.29
- Negative: negative Net income
- Negative: 0 < Inventory ratio change, % of 0.49
- Negative: Investing cash flow per share, $ of -3.65 <= -3.48
- Negative: Industry operating cash flow per share per price (median), % of -5.15 <= 3.85
- Positive: Industry inventory ratio change (median), % of 0.19 <= 0.49
Short-term ICUI quotes
Long-term ICUI plot with estimates
Financial data
| YTD | 2021-12-31 | 2022-12-31 | 2023-12-31 |
|---|---|---|---|
| Operating Revenue | $1,316.31MM | $2,280.00MM | $2,259.13MM |
| Operating Expenses | $1,193.06MM | $2,322.89MM | $2,236.30MM |
| Operating Income | $123.25MM | $-42.90MM | $22.82MM |
| Non-Operating Income | $-0.06MM | $-71.51MM | $-101.12MM |
| Interest Expense | $0.86MM | $66.38MM | $102.73MM |
| R&D Expense | $47.50MM | $92.98MM | $85.34MM |
| Income(Loss) | $123.19MM | $-114.41MM | $-78.30MM |
| Taxes | $20.05MM | $-40.12MM | $-48.64MM |
| Profit(Loss) | $103.14MM | $-74.29MM | $-29.66MM |
| Stockholders Equity | $1,616.03MM | $2,089.93MM | $2,123.41MM |
| Inventory | $290.24MM | $696.01MM | $709.36MM |
| Assets | $1,880.74MM | $4,515.64MM | $4,378.44MM |
| Operating Cash Flow | $267.54MM | $-62.13MM | $166.20MM |
| Capital expenditure | $81.17MM | $99.33MM | $93.67MM |
| Investing Cash Flow | $-90.69MM | $-1,909.47MM | $-87.95MM |
| Financing Cash Flow | $-16.87MM | $1,637.03MM | $-35.98MM |
| Earnings Per Share* | $4.86 | $-3.11 | $-1.23 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.